Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C

Journal of Hepatology

Volumn 59, Issue 4, 2013, Pages 696-700

  Squadrito, Giovanni ^a   Cacciola, Irene ^a   Alibrandi, Angela ^b   Pollicino, Teresa ^a,b   Raimondo, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cirrhosis Hepatocellular carcinoma; HBsAg negative; HBV DNA; Liver biopsy

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; DNA VIRUS; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; TREATMENT RESPONSE;

CHC; CHRONIC HEPATITIS C; CIRRHOSIS; HBSAG; HBSAG-NEGATIVE; HBV; HBV DNA; HCC; HCV; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA; IFNΑ; INTERFERON-Α; LDW; LIVER BIOPSY; LIVER DISEASE WORSENING; OBI; OCCULT HBV INFECTION; OLT; ORTHOTOPIC LIVER TRANSPLANTATION; SUSTAINED VIROLOGICAL RESPONSE; SVR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COINFECTION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884411951     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.05.043     Document Type: Article

References (25)

1. G. Raimondo, J.P. Allain, M.R. Brunetto, M.A. Buendia, D.S. Chen, and M. Colombo Statements from the Taormina expert meeting on occult hepatitis B virus infection J Hepatol 49 2008 652 657
2. M. Torbenson, and D.L. Thomas Occult hepatitis B Lancet Infect Dis 2 2002 479 486 (Pubitemid 34826853)
3. G. Raimondo, T. Pollicino, I. Cacciola, and G. Squadrito Occult hepatitis B virus infection J Hepatol 46 2007 160 170 (Pubitemid 44827430)
4. G. Raimondo, G. Caccamo, R. Filomia, and T. Pollicino Occult HBV infection Semin Immunopathol 35 2013 39 52
5. G. Raimondo Occult hepatitis B virus infection and liver disease: fact or fiction? J Hepatol 34 2001 471 473 (Pubitemid 32240829)
6. Y. Shintani, H. Yotsuyanagi, K. Moriya, H. Fujie, T. Tsutsumi, and T. Takayama The significance of Hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C Cancer 88 2000 2478 2486 (Pubitemid 30331953)
7. A. Tamori, T. Hayashi, M. Shinzaki, S. Kobayashi, S. Iwai, and M. Enomoto Frequent detection of Hepatitis B virus DNA in hepatocellular carcinoma in patients with sustained virologic response for hepatitis C virus J Med Virol 81 2009 1009 1014
8. M. Obika, T. Shinji, S. Fujioka, R. Terada, H. Ryuko, and A. Lwin Hepatitis B virus DNA in liver tissue and risk of hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study Intervirology 51 2008 59 68 (Pubitemid 351489179)
9. J.H. Kao, P.J. Chen, M.Y. Lai, and D.S. Chen Occult hepatitis B infection and clinic outcomes of patients with chronic hepatitis C J Clin Microbiol 40 2002 1207 1209
10. Y. Miura, A. Shibuya, S. Adachi, A. Takeuchi, T. Tsuchihashi, and T. Nakazawa Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails Hepatol Res 38 2008 546 556 (Pubitemid 351622280)
11. S. Adachi, A. Shibuya, Y. Miura, A. Takeuchi, T. Nakazawa, and K. Saigenji Impact of occult hepatitis B infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus Scand J Gastroenterol 43 2008 849 856 (Pubitemid 351918521)
12. Y. Shi, Y.H. Wu, W. Wu, W.J. Zhang, J. Yang, and Z. Chen Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis Liver Int 32 2012 231 240
13. K. Shetty, M. Hussain, L. Nei, K.R. Reddy, and A.S. Lok Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C Liver Transpl 14 2008 534 540 (Pubitemid 351524410)
14. A.S. Lok, J.E. Everhart, A.M. Di Bisceglie, H.Y. Kim, M. Hussain, and T.R. Morgan Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C Hepatology 54 2011 434 442
15. D. Shouval What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C? Liver Transpl 14 2008 418 419 (Pubitemid 351524394)
16. I. Cacciola, T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando, and G. Raimondo Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 341 1999 22 26 (Pubitemid 29293716)
17. T. Pollicino, G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, and A. Craxi Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 102 110 (Pubitemid 38040728)
18. G. Squadrito, T. Pollicino, I. Cacciola, G. Caccamo, D. Villari, and T. La Masa Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients Cancer 106 2006 1326 1330 (Pubitemid 43363910)
19. C. Brechot Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms Gastroenterology 127 2004 S56 S61
20. T. Pollicino, C. Saitta, and G. Raimondo Hepatocellular carcinoma: the point of view of the hepatitis B virus Carcinogenesis 32 2011 1122 1132
21. K.Q. Hu Occult hepatitis B virus infection and its clinical implications J Viral Hepat 9 2002 243 257
22. I. Chemin, and C. Trepo Clinical impact of occult HBV infections J Clin Virol 34 2005 S15 S21
23. R. Kannangai, P. Vivekanandan, D. Netski, S. Mehta, G.D. Kirk, and D.L. Thomas Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection J Clin Virol 39 2007 101 105 (Pubitemid 46777424)
24. I. Chemin, O. Guillaud, P.C. Queyron, and C. Trepo Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection J Hepatol 51 2009 824 825
25. G. Raimondo, T. Pollicino, and G. Squadrito What is the clinical impact of occult hepatitis B virus infection? Lancet 365 2005 638 640 (Pubitemid 40260874)